Workers' Comp

Press Release - Drug Formulary Hearing

March 18, 2017
2 MIN READ

DWC ISSUES NOTICE OF PUBLIC HEARING FOR DRUG FORMULARY REGULATIONS 

DOWNERS GROVE, Ill. (March 20, 2017) - The Department of Industrial Relations’ Division of Workers’ Compensation (DWC) published the California Formulary final draft rules on March 10, 2017. The proposed rulemaking implements Assembly Bill 1124 (Statutes 2015, Chapter 525), which mandated the adoption of an evidence-based workers’ compensation drug formulary into the Medical Treatment Utilization Schedule (MTUS) by July 1, 2017. 

To accept drug formulary regulation comments, the DWC has issued a notice of public hearing taking place on May 1, 2017. The public hearing is scheduled for 10 a.m. in the auditorium of the Elihu Harris Building, 1515 Clay Street, Oakland, CA 94612. Members of the public may also submit written comments on the regulations until 5 p.m. May 1st. The DWC will consider all public comments, and may modify the proposed regulations for consideration during an additional 15-day public comment period. Coventry will be providing comments and plans to attend the public hearing. 

For more information on the notice of rulemaking, text of the regulations, and the initial statement of reasons visit the DWC rulemaking web page. Information about the rulemaking process can be found on the Office of Administrative Law’s (OAL) website. 

Coventry client specific information regarding formulary adoption will be provided through our Account Management Team. If you have additional questions, please contact your account manager or info@cvty.com. 

About Coventry 
Coventry offers workers' compensation, auto and disability care- and cost-management solutions for employers, insurance carriers and third-party administrators. With roots in both clinical and network services, Coventry leverages more than 30 years of industry experience, knowledge and data analytics. 

###